Publications found:
55,654
Sort by:
Sickle Cell Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SICKLE CELL DISEASE PIPELINE REPORT INCLUDES Panorama of Sickle Cell Disease pipeline markets including statistics on therapeutic drugs and companies involved Sickle Cell Disease Pipeline candidates across various development ...
August 2018
150 pages
Sinusitis (Sinus Infection) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SINUSITIS (SINUS INFECTION) PIPELINE REPORT INCLUDES Panorama of Sinusitis (Sinus Infection) pipeline markets including statistics on therapeutic drugs and companies involved Sinusitis (Sinus Infection) Pipeline candidates across various development ...
August 2018
70 pages
Skin And Soft Tissue Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... . SCOPE OF SKIN AND SOFT TISSUE INFECTIONS PIPELINE REPORT INCLUDES Panorama of Skin And Soft Tissue Infections pipeline markets including statistics on therapeutic drugs and companies involved Skin And Soft Tissue Infections Pipeline ...
August 2018
30 pages
Sleep Apnea R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SLEEP APNEA PIPELINE REPORT INCLUDES Panorama of Sleep Apnea pipeline markets including statistics on therapeutic drugs and companies involved Sleep Apnea Pipeline candidates across various development ...
August 2018
50 pages
Smallpox R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF SMALLPOX PIPELINE REPORT INCLUDES Panorama of Smallpox pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Smoking Addiction R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SMOKING ADDICTION PIPELINE REPORT INCLUDES Panorama of Smoking Addiction pipeline markets including statistics on therapeutic drugs and companies involved Smoking Addiction Pipeline candidates across various development ...
August 2018
70 pages
Spinal Cord Injury R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SPINAL CORD INJURY PIPELINE REPORT INCLUDES Panorama of Spinal Cord Injury pipeline markets including statistics on therapeutic drugs and companies involved Spinal Cord Injury Pipeline candidates across various development ...
August 2018
160 pages
Spinal Muscular Atrophy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SPINAL MUSCULAR ATROPHY PIPELINE REPORT INCLUDES Panorama of Spinal Muscular Atrophy pipeline markets including statistics on therapeutic drugs and companies involved Spinal Muscular Atrophy Pipeline candidates across various development ...
August 2018
90 pages
Spinocerebellar Ataxia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SPINOCEREBELLAR ATAXIA PIPELINE REPORT INCLUDES Panorama of Spinocerebellar Ataxia pipeline markets including statistics on therapeutic drugs and companies involved Spinocerebellar Ataxia Pipeline candidates across various development ...
August 2018
50 pages
Status Epilepticus R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF STATUS EPILEPTICUS PIPELINE REPORT INCLUDES Panorama of Status Epilepticus pipeline markets including statistics on therapeutic drugs and companies involved Status Epilepticus Pipeline candidates across various development ...
August 2018
50 pages
Streptococcal Pneumonia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF STREPTOCOCCAL PNEUMONIA PIPELINE REPORT INCLUDES Panorama of Streptococcal Pneumonia pipeline markets including statistics on therapeutic drugs and companies involved Streptococcal Pneumonia Pipeline candidates across various development ...
August 2018
130 pages
Streptococcus pyogenes Infection R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF STREPTOCOCCUS PYOGENES INFECTION PIPELINE REPORT INCLUDES Panorama of Streptococcus pyogenes Infection pipeline markets including statistics on therapeutic drugs and companies involved Streptococcus pyogenes Infection Pipeline candidates across various development ...
August 2018
30 pages
Synovial Sarcoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SYNOVIAL SARCOMA PIPELINE REPORT INCLUDES Panorama of Synovial Sarcoma pipeline markets including statistics on therapeutic drugs and companies involved Synovial Sarcoma Pipeline candidates across various development ...
August 2018
170 pages
Systemic Idiopathic Juvenile Arthritis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF SYSTEMIC IDIOPATHIC JUVENILE ARTHRITIS PIPELINE REPORT INCLUDES Panorama of Systemic Idiopathic Juvenile Arthritis pipeline markets including statistics on therapeutic drugs and companies involved Systemic Idiopathic Juvenile Arthritis Pipeline candidates across ...
August 2018
40 pages
Systemic Mastocytosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SYSTEMIC MASTOCYTOSIS PIPELINE REPORT INCLUDES Panorama of Systemic Mastocytosis pipeline markets including statistics on therapeutic drugs and companies involved Systemic Mastocytosis Pipeline candidates across various development ...
August 2018
110 pages
Systemic Sclerosis (Scleroderma) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SYSTEMIC SCLEROSIS (SCLERODERMA) PIPELINE REPORT INCLUDES Panorama of Systemic Sclerosis (Scleroderma) pipeline markets including statistics on therapeutic drugs and companies involved Systemic Sclerosis (Scleroderma) Pipeline candidates across various development ...
August 2018
220 pages
Tetanus R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF TETANUS PIPELINE REPORT INCLUDES Panorama of Tetanus pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Thalassemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF THALASSEMIA PIPELINE REPORT INCLUDES Panorama of Thalassemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
120 pages
Thrombocytopenia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF THROMBOCYTOPENIA PIPELINE REPORT INCLUDES Panorama of Thrombocytopenia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
130 pages
Thromboembolism R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF THROMBOEMBOLISM PIPELINE REPORT INCLUDES Panorama of Thromboembolism pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Thrombotic Thrombocytopenic Purpura R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF THROMBOTIC THROMBOCYTOPENIC PURPURA PIPELINE REPORT INCLUDES Panorama of Thrombotic Thrombocytopenic Purpura pipeline markets including statistics on therapeutic drugs and companies involved Thrombotic Thrombocytopenic Purpura Pipeline candidates across various development ...
August 2018
50 pages
Thymic Carcinoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF THYMIC CARCINOMA PIPELINE REPORT INCLUDES Panorama of Thymic Carcinoma pipeline markets including statistics on therapeutic drugs and companies involved Thymic Carcinoma Pipeline candidates across various development ...
August 2018
70 pages
Tinea pedis (Athlete Foot) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF TINEA PEDIS (ATHLETE FOOT) PIPELINE REPORT INCLUDES Panorama of Tinea pedis (Athlete Foot) pipeline markets including statistics on therapeutic drugs and companies involved Tinea pedis (Athlete Foot) Pipeline candidates across ...
August 2018
30 pages
Tinnitus R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF TINNITUS PIPELINE REPORT INCLUDES Panorama of Tinnitus pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Tourette Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF TOURETTE SYNDROME PIPELINE REPORT INCLUDES Panorama of Tourette Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Tourette Syndrome Pipeline candidates across various development ...
August 2018
70 pages
Toxoplasmosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF TOXOPLASMOSIS PIPELINE REPORT INCLUDES Panorama of Toxoplasmosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Traveler’s Diarrhea R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF TRAVELER’S DIARRHEA PIPELINE REPORT INCLUDES Panorama of Traveler’s Diarrhea pipeline markets including statistics on therapeutic drugs and companies involved Traveler’s Diarrhea Pipeline candidates across various development ...
August 2018
40 pages
Trigeminal Neuralgia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF TRIGEMINAL NEURALGIA PIPELINE REPORT INCLUDES Panorama of Trigeminal Neuralgia pipeline markets including statistics on therapeutic drugs and companies involved Trigeminal Neuralgia Pipeline candidates across various development ...
August 2018
40 pages
Tularaemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF TULARAEMIA PIPELINE REPORT INCLUDES Panorama of Tularaemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Typhoid Fever R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF TYPHOID FEVER PIPELINE REPORT INCLUDES Panorama of Typhoid Fever pipeline markets including statistics on therapeutic drugs and companies involved Typhoid Fever Pipeline candidates across various development ...
August 2018
40 pages
Ureter Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF URETER CANCER PIPELINE REPORT INCLUDES Panorama of Ureter Cancer pipeline markets including statistics on therapeutic drugs and companies involved Ureter Cancer Pipeline candidates across various development ...
August 2018
120 pages
Urinary Incontinence R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF URINARY INCONTINENCE PIPELINE REPORT INCLUDES Panorama of Urinary Incontinence pipeline markets including statistics on therapeutic drugs and companies involved Urinary Incontinence Pipeline candidates across various development ...
August 2018
60 pages
Usher Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF USHER SYNDROME PIPELINE REPORT INCLUDES Panorama of Usher Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Usher Syndrome Pipeline candidates across various development ...
August 2018
30 pages
Uterine Leiomyoma (Uterine Fibroids) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF UTERINE LEIOMYOMA (UTERINE FIBROIDS) PIPELINE REPORT INCLUDES Panorama of Uterine Leiomyoma (Uterine Fibroids) pipeline markets including statistics on therapeutic drugs and companies involved Uterine Leiomyoma (Uterine Fibroids) Pipeline candidates across ...
August 2018
80 pages
Uveal Melanoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF UVEAL MELANOMA PIPELINE REPORT INCLUDES Panorama of Uveal Melanoma pipeline markets including statistics on therapeutic drugs and companies involved Uveal Melanoma Pipeline candidates across various development ...
August 2018
150 pages
Uveitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF UVEITIS PIPELINE REPORT INCLUDES Panorama of Uveitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Vaginal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF VAGINAL CANCER PIPELINE REPORT INCLUDES Panorama of Vaginal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Vaginal Cancer Pipeline candidates across various development ...
August 2018
100 pages
Varicella Zoster Infection (HHV-3) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF VARICELLA ZOSTER INFECTION (HHV-3) PIPELINE REPORT INCLUDES Panorama of Varicella Zoster Infection (HHV-3) pipeline markets including statistics on therapeutic drugs and companies involved Varicella Zoster Infection (HHV-3) Pipeline candidates across ...
August 2018
80 pages
Vasculitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF VASCULITIS PIPELINE REPORT INCLUDES Panorama of Vasculitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Venous Leg Ulcers (Crural ulcer) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF VENOUS LEG ULCERS (CRURAL ULCER) PIPELINE REPORT INCLUDES Panorama of Venous Leg Ulcers (Crural ulcer) pipeline markets including statistics on therapeutic drugs and companies involved Venous Leg Ulcers (Crural ulcer) Pipeline candidates across ...
August 2018
50 pages
Ventilator Associated Pneumonia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF VENTILATOR ASSOCIATED PNEUMONIA PIPELINE REPORT INCLUDES Panorama of Ventilator Associated Pneumonia pipeline markets including statistics on therapeutic drugs and companies involved Ventilator Associated Pneumonia Pipeline candidates across various development ...
August 2018
110 pages
Ventricular Tachycardia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF VENTRICULAR TACHYCARDIA PIPELINE REPORT INCLUDES Panorama of Ventricular Tachycardia pipeline markets including statistics on therapeutic drugs and companies involved Ventricular Tachycardia Pipeline candidates across various development ...
August 2018
40 pages
Viral Conjunctivitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF VIRAL CONJUNCTIVITIS PIPELINE REPORT INCLUDES Panorama of Viral Conjunctivitis pipeline markets including statistics on therapeutic drugs and companies involved Viral Conjunctivitis Pipeline candidates across various development ...
August 2018
30 pages
Visceral Pain R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF VISCERAL PAIN PIPELINE REPORT INCLUDES Panorama of Visceral Pain pipeline markets including statistics on therapeutic drugs and companies involved Visceral Pain Pipeline candidates across various development ...
August 2018
40 pages
Vitiligo R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF VITILIGO PIPELINE REPORT INCLUDES Panorama of Vitiligo pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
70 pages
VRSA Infection R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF VRSA INFECTION PIPELINE REPORT INCLUDES Panorama of VRSA Infection pipeline markets including statistics on therapeutic drugs and companies involved VRSA Infection Pipeline candidates across various development ...
August 2018
40 pages
Vulvar Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF VULVAR CANCER PIPELINE REPORT INCLUDES Panorama of Vulvar Cancer pipeline markets including statistics on therapeutic drugs and companies involved Vulvar Cancer Pipeline candidates across various development ...
August 2018
100 pages
Vulvovaginal Candidiasis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF VULVOVAGINAL CANDIDIASIS PIPELINE REPORT INCLUDES Panorama of Vulvovaginal Candidiasis pipeline markets including statistics on therapeutic drugs and companies involved Vulvovaginal Candidiasis Pipeline candidates across various development ...
August 2018
50 pages
